全文获取类型
收费全文 | 1636篇 |
免费 | 112篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 119篇 |
妇产科学 | 65篇 |
基础医学 | 182篇 |
口腔科学 | 33篇 |
临床医学 | 183篇 |
内科学 | 329篇 |
皮肤病学 | 24篇 |
神经病学 | 86篇 |
特种医学 | 326篇 |
外科学 | 161篇 |
综合类 | 15篇 |
预防医学 | 58篇 |
眼科学 | 17篇 |
药学 | 56篇 |
中国医学 | 2篇 |
肿瘤学 | 102篇 |
出版年
2023年 | 6篇 |
2022年 | 3篇 |
2021年 | 24篇 |
2020年 | 11篇 |
2019年 | 20篇 |
2018年 | 29篇 |
2017年 | 15篇 |
2016年 | 25篇 |
2015年 | 45篇 |
2014年 | 41篇 |
2013年 | 55篇 |
2012年 | 65篇 |
2011年 | 56篇 |
2010年 | 57篇 |
2009年 | 51篇 |
2008年 | 48篇 |
2007年 | 62篇 |
2006年 | 48篇 |
2005年 | 57篇 |
2004年 | 49篇 |
2003年 | 31篇 |
2002年 | 25篇 |
2001年 | 25篇 |
2000年 | 31篇 |
1999年 | 35篇 |
1998年 | 100篇 |
1997年 | 70篇 |
1996年 | 83篇 |
1995年 | 60篇 |
1994年 | 56篇 |
1993年 | 64篇 |
1992年 | 19篇 |
1991年 | 13篇 |
1990年 | 17篇 |
1989年 | 41篇 |
1988年 | 32篇 |
1987年 | 38篇 |
1986年 | 23篇 |
1985年 | 30篇 |
1984年 | 25篇 |
1983年 | 16篇 |
1982年 | 23篇 |
1981年 | 26篇 |
1980年 | 28篇 |
1979年 | 7篇 |
1978年 | 16篇 |
1977年 | 18篇 |
1976年 | 20篇 |
1975年 | 14篇 |
1930年 | 1篇 |
排序方式: 共有1761条查询结果,搜索用时 15 毫秒
21.
22.
ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome 总被引:11,自引:3,他引:11
Picketts DJ; Higgs DR; Bachoo S; Blake DJ; Quarrell OW; Gibbons RJ 《Human molecular genetics》1996,5(12):1899-1907
It was shown recently that mutations of the ATRX gene give rise to a
severe, X-linked form of syndromal mental retardation associated with alpha
thalassaemia (ATR-X syndrome). In this study, we have characterised the
full-length cDNA and predicted structure of the ATRX protein. Comparative
analysis shows that it is an entirely new member of the SNF2 subgroup of a
superfamily of proteins with similar ATPase and helicase domains. ATRX
probably acts as a regulator of gene expression. Definition of its genomic
structure enabled us to identify four novel splicing defects by screening
52 affected individuals. Correlation between these and previously
identified mutations with variations in the ATR-X phenotype provides
insights into the pathophysiology of this disease and the normal role of
the ATRX protein in vivo.
相似文献
23.
24.
Evolutionary silencing of the human elastase I gene (ELA1) 总被引:6,自引:0,他引:6
25.
Jou YH 《Shinrigaku kenkyu : The Japanese journal of psychology》2003,73(6):494-501
The present paper examined whether people employ different support-gaining strategies toward various sources of support. In Study 1, 231 Taiwanese undergraduates were asked the frequency of each strategy they used for three support types: tangible, psychological, and informational, from four support sources: parents, professors, same-sex close friends, and same-sex acquaintances. In Study 2, 363 undergraduates were asked to think of an opposite-sex friend: an acquaintance, a close friend, or romantic partner, and write the frequency of each strategy they used. Results of ANOVA indicated that main effects of source and strategy and a three-way interaction of source by strategy by gender were significant. In Study 1, the students used various strategies most frequently toward parents and same-sex close friends, and least frequently to professors, and in Study 2, more frequently to close friends and romantic partners than to acquaintances. The strategy most often used was reasoning, followed by entreaty, roundabout request, exploitation, promise of reward, exhortation, and threat, in the descending order. No effect was found for the support type factor. 相似文献
26.
Huisman JA; Paulussen RJ; Geurts TB; Odink J; Rekers H 《Human reproduction (Oxford, England)》1997,12(1):34-38
The objective was to demonstrate bioequivalence between s.c. and i.m.
administration of Humegon (FSH/LH ratio 1:1) and Normegon (FSH/LH ratio
3:1). In two randomized, single-centre, cross-over studies, 18 healthy
volunteers on each formulation were assigned to one of the two
administration sequences. Subjects were given single doses of one of the
above gonadotrophins after endogenous gonadotrophin production had first
been suppressed using high-dose oral contraceptive. Subsequently, rate
(Cmax, tmax) and extent (AUC) of absorption of follicle stimulating hormone
(FSH) and luteinizing hormone (LH) were determined for 14 days. For Cmax
and AUC, analysis of variance (ANOVA) was performed on log-transformed data
and for tmax ANOVA was performed on ranks. Intramuscular and s.c.
injections of Humegon were bioequivalent with respect to the main
pharmacokinetic parameters, being AUC and Cmax of FSH absorption.
Intramuscular and s.c. injections of Normegon were bioequivalent with
respect to the AUC of FSH and not bioequivalent with respect to the Cmax of
FSH. For tmax of FSH as well as for most LH variables of both preparations,
bioequivalence could not be proven due to the high intra- and
interindividual variability and/or concentrations being close to the
detection limit. Thus, the main pharmacokinetic FSH variables after i.m.
and s.c. administration of Humegon and Normegon were bioequivalent.
相似文献
27.
28.
Lesions of the articular surfaces of the knee have been managed by various techniques over the last 50 years. Surgical management has involved: excising the damaged area, refashioning the underlying bone to produce a fibrous response, and introducing allograft, autograft and synthetic materials to encourage a repair matrix. The techniques and their pitfalls are reviewed and discussed, and suggestions made as to the direction of future studies for the repair of osteochondral lesions in the painful knee. 相似文献
29.
Suraj Suresh Mohammad Siddiqui Mouhanna Abu Ghanimeh Jessica Jou Stephen Simmer Vivek Mendiratta Sarah Russell Mustafa Al-Shammari Abigail Chatfield Eva Alsheik Duyen Dang Jeffrey Genaw Tobias Zuchelli 《Obesity research & clinical practice》2021,15(2):172-176
BackgroundAlthough recent studies have shown an association between obesity and adverse coronavirus disease 2019 (COVID-19) patient outcomes, there is a paucity in large studies focusing on hospitalized patients. We aimed to analyze outcomes associated with obesity in a large cohort of hospitalized COVID-19 patients.MethodsWe performed a retrospective study at a tertiary care health system of adult patients with COVID-19 who were admitted between March 1 and April 30, 2020. Patients were stratified by body mass index (BMI) into obese (BMI ≥ 30 kg/m 2) and non-obese (BMI < 30 kg/m 2) cohorts. Primary outcomes were mortality, intensive care unit (ICU) admission, intubation, and 30-day readmission.ResultsA total of 1983 patients were included of whom 1031 (51.9%) had obesity and 952 (48.9%) did not have obesity. Patients with obesity were younger (P < 0.001), more likely to be female (P < 0.001) and African American (P < 0.001) compared to patients without obesity. Multivariable logistic models adjusting for differences in age, sex, race, medical comorbidities, and treatment modalities revealed no difference in 60-day mortality and 30-day readmission between obese and non-obese groups. In these models, patients with obesity had increased odds of ICU admission (adjusted OR, 1.37; 95% CI, 1.07?1.76; P = 0.012) and intubation (adjusted OR, 1.37; 95% CI, 1.04?1.80; P = 0.026).ConclusionsObesity in patients with COVID-19 is independently associated with increased risk for ICU admission and intubation. Recognizing that obesity impacts morbidity in this manner is crucial for appropriate management of COVID-19 patients. 相似文献
30.